Reuters logo
10 months ago
BRIEF-KemPharm announces licensing agreement with Acura
October 18, 2016 / 11:11 AM / 10 months ago

BRIEF-KemPharm announces licensing agreement with Acura

Oct 18 (Reuters) - KemPharm Inc -

* KemPharm announces licensing agreement with Acura Pharmaceuticals for aversion abuse-deterrent technology

* Says agreement provided for an upfront cash payment of $3.5 million to Acura at execution

* Agreement provided for an upfront cash payment of $3.5 million to Acura at execution

* Kempharm will solely own intellectual property resulting from any new product development

* Acura is eligible to receive royalty at low single-digit rate based on commercial sales by Co of all products developed under agreement

* Additional payments are provided in agreement should KemPharm exercise its option to use Acura's aversion technology with more than three products

* Agreement also grants KemPharm development and commercialization rights for up to three IR product candidates containing two of KemPharm's opioid prodrugs Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below